At the 67th World Health Assembly in Geneva in May 2014, a resolution was adopted on Health intervention and technology assessment in support of universal health coverage. Prof David Haslam, Chair of NICE, representing the UK Mission Geneva, addressed the Assembly during a panel session on the role

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? Thavorncharoensap M1, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P 1Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand ; Heal

It was quite an experience this time for it was both hectic and enriching. Pempa and I (Deepika Adhikari) are researchers from Bhutan and we were recently in Thailand for training and simultaneously attended the Prince Mahidol Award Conference (PMAC) too. We are grateful to the Health Intervention a

Inequalities of health exist across the globe, between genders, socioeconomic groups, ethnicities, geographic regions, and many other characteristics. Health interventions rarely, if ever, have a uniform impact on all the groups that are eligible to receive them, yet most economic evaluations only q

Together with the Mahidol Oxford Tropical Medicine Research Unit (MORU), HITAP has been engaged in assisting with building technical capacity for HTA and more broadly, evidence-informed decisions for health care in Laos since 2019. Towards this objective, HITAP hosted researchers from University of Health Sciences (UHS) and Lao-Oxford-Mahosot Hospi

Veronika J Wirtz*, Hans V Hogerzeil*, Andrew L Gray*, Maryam Bigdeli, Cornelis P de Joncheere, Margaret A Ewen, Martha Gyansa-Lutterodt, Sun Jing, Vera L Luiza, Regina M Mbindyo, Helene Möller, Corrina Moucheraud, Bernard Pécoul, Lembit Rägo, Arash Rashidian, Dennis Ross-Degnan, Peter N Stephens,

Abstract A trend towards charging for access to research findings, tools and databases is becoming more prominent globally. But charging for the use of research tools and databases that are vital to research supporting national and international policy development might be unjustified. Financial

Because the quality of cost-effectiveness studies related to the Thai context is still limited, the Thai health technology assessment guidelines have been firstly developed in Thailand for researchers to stimulate the provision of standardized, reliable and good quality information which can be used by policy makers and healthcare personnel for mak

On 17th September 2018, Sarah Garner, coordinator of the Innovation, Access and Use team under the Essential Medicines and Health Products program, World Health Organization, had an informal meeting at the Health Intervention and Technology Assessment Program (HITAP). She was eager to learn about HI

Cost-Effectiveness Analysis of Thiazolidinediones in Uncontrolled Type 2 Diabetic Patients Receiving Sulfonylureas and Metformin in Thailand. Suphachai Chirakup1,2 Nathorn Chaiyakunapruk1,3,4 Usa Chaikledkeaw5,6 Petcharat Pongcharoensuk5 Boonsong Ongphiphadhanakul7 Stephane Roze8 William J. Valenti